1. Design of the silent cerebral infarct transfusion (SIT) trial. Casella JF, King AA, Barton B, White DA, Noetzel MJ, Ichord RN, Terrill C, Hirtz D, McKinstry RC, Strouse JJ, Howard TH, Coates TD, Minniti CP, Campbell AD, Vendt BA, Lehmann H, Debaun MR (2010) Pediatr Hematol Oncol 27(2): 69-89
    › Citation · 20201689 (PubMed) · PMC5572477 (PubMed Central)
  2. Addition of H19 'loss of methylation testing' for Beckwith-Wiedemann syndrome (BWS) increases the diagnostic yield. Lennerz JK, Timmerman RJ, Grange DK, DeBaun MR, Feinberg AP, Zehnbauer BA (2010) J Mol Diagn 12(5): 576-88
    › Citation · 20616360 (PubMed) · PMC2928421 (PubMed Central)
  3. Urinary cysteinyl leukotriene E4 significantly increases during pain in children and adults with sickle cell disease. Field JJ, Strunk RC, Knight-Perry JE, Blinder MA, Townsend RR, DeBaun MR (2009) Am J Hematol 84(4): 231-3
    › Citation · 19291727 (PubMed)
  4. Urinary cysteinyl leukotriene E(4) is associated with increased risk for pain and acute chest syndrome in adults with sickle cell disease. Field JJ, Krings J, White NL, Yan Y, Blinder MA, Strunk RC, Debaun MR (2009) Am J Hematol 84(3): 158-60
    › Citation · 19127594 (PubMed)
  5. The Sickle Cell Sabbath: a community program increases first-time blood donors in the African American faith community. Price CL, Johnson MT, Lindsay T, Dalton D, Watkins AR, DeBaun MR (2009) Transfusion 49(3): 519-23
    › Citation · 19040492 (PubMed)
  6. Strategies for recruiting and retaining minorities. DeBaun MR, Gorelick PB, Som S (2009) Front Neurol Neurosci : 118-120
    › Citation · 19478507 (PubMed)
  7. Silent Cerebral Infarct Transfusion (SIT) trial imaging core: application of novel imaging information technology for rapid and central review of MRI of the brain. Vendt BA, McKinstry RC, Ball WS, Kraut MA, Prior FW, Barton B, Casella JF, DeBaun MR (2009) J Digit Imaging 22(3): 326-43
    › Citation · 18398653 (PubMed) · PMC2801625 (PubMed Central)
  8. Risk factors for hospital readmission within 30 days: a new quality measure for children with sickle cell disease. Frei-Jones MJ, Field JJ, DeBaun MR (2009) Pediatr Blood Cancer 52(4): 481-5
    › Citation · 19058209 (PubMed) · PMC2730199 (PubMed Central)
  9. Multi-modal intervention and prospective implementation of standardized sickle cell pain admission orders reduces 30-day readmission rate. Frei-Jones MJ, Field JJ, DeBaun MR (2009) Pediatr Blood Cancer 53(3): 401-5
    › Citation · 19422031 (PubMed) · PMC2722244 (PubMed Central)
  10. Lower airway obstruction is associated with increased morbidity in children with sickle cell disease. Boyd JH, DeBaun MR, Morgan WJ, Mao J, Strunk RC (2009) Pediatr Pulmonol 44(3): 290-6
    › Citation · 19205057 (PubMed) · PMC2823250 (PubMed Central)